mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-09 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
6e-07 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.19 |
4e-05 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.19 |
8e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0008 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0009 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.001 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |